[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ap4b1-gene":3},{"name":4,"total":5,"trials":6},"AP4B1 Gene",3,[7,14,21],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT06585605","A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes",[],"RECRUITING","2026-08-03T02:05:54.503205Z","2026-06-02T11:21:24.705937Z",{"nct_id":15,"title":16,"phases":17,"status":11,"updated_at":19,"content_modified":20},"NCT06692712","Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.",[18],"Phase 3","2026-08-03T03:03:24.588072Z","2026-05-05T02:43:28.971788Z",{"nct_id":22,"title":23,"phases":24,"status":26,"updated_at":27,"content_modified":28},"NCT06948019","Safety and Efficacy of AAV9\u002FAP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47)",[25],"Phase 1\u002FPhase 2","NOT_YET_RECRUITING","2026-08-03T03:53:05.241597Z","2026-05-05T02:43:26.954417Z"]